bupivacaine + paracetamol

bupivacaine + paracetamol is a combination regimen consisting of the long-acting amide local anesthetic bupivacaine and the non-opioid analgesic paracetamol. Bupivacaine functions by blocking voltage-gated sodium channels (specifically the alpha subunit), which prevents the generation and conduction of nerve impulses, thereby providing regional anesthesia and analgesia. Paracetamol (acetaminophen) provides central analgesia and antipyresis, primarily through the inhibition of cyclooxygenase (COX-1 and COX-2) enzymes and the subsequent reduction of prostaglandin synthesis in the central nervous system. This combination or comparative regimen has been investigated by Sohag University for the management of postoperative pain, particularly in patients undergoing open inguinal hernia repair. In this clinical context, bupivacaine is typically administered via a Quadratus Lumborum (QL) block to provide targeted regional pain relief, while paracetamol is administered systemically (intravenously) as a conventional analgesic component of multimodal therapy.

Other names

bupivacaine and paracetamolbupivacaine/paracetamol